The Effects of an Integrative Aromatherapy Olfactory Rehabilitation Program on Aging-related Smell Dysfunction (Presbyosmia): A Mixed-Methods Study

The Effects of an Integrative Aromatherapy Olfactory Rehabilitation Program on Presbyosmia: A Mixed-Methods Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0010015

Enrollment

Registered

2024-12-09

Start date

2024-12-10

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : [Experimental Group] Aromatherapy-Integrated Olfactory Rehabilitation Program Duration: 12 weeks Frequency: Every 2 weeks, 6 sessions total Time: 60 minutes/session Content: a) Information pr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Individuals who understand the purpose of the study and agree to participate in the research - Adults aged 65 years or older - Individuals with age-related olfactory dysfunction or loss for more than 3 months, or those who have been medically diagnosed with presbyosmia: score less than 11 points on the Sniffin' Sticks Screening 12 Test (Hummel T, 2001) - Individuals capable of communication sufficient to understand olfactory function tests and questionnaire content

Exclusion criteria

Exclusion criteria: - Individuals with aversion or allergies to essential oils - Those with nasal polyps, chronic sinusitis, or severe symptoms of allergic rhinitis - Those who have undergone nasal surgery within the past 3 years, or have upper respiratory tract infection or nasal congestion within the past 2 weeks - Those with specific exposure to hazardous chemicals or toxins within the past 3 years - Individuals with diseases affecting olfactory function (including olfactory groove meningioma, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurological disorders) - Those taking medications that may affect olfactory function, such as hyperthyroidism treatment drugs - Individuals undergoing chemotherapy or radiation therapy for cancer or other severe diseases - Those with limitations in language and intervention performance or mental illness - Individuals who have reported olfactory symptoms due to COVID-19

Design outcomes

Primary

Measure	Time frame
Olfactory Function (TDI: Threshold, Discrimination, Identification score);Olfactory VAS (Visual Analogue Scale)	—

Secondary

Measure	Time frame
Cognitive Function;Depression;Quality of Life;Self-efficacy	—

Countries

Korea, Republic of

Contacts

Public ContactEun Joo Lee

CHA University

animaflos@gmail.com+82-31-881-7082

Outcome results